PEDF, mouse recombinant protein
Pigment Epithelium-derived Factor; Stromal Cell-derived Factor 3; Serpin F1; Caspin
- SPECIFICATION
- CITATIONS
- PROTOCOLS
- BACKGROUND
Primary Accession | P97298 |
---|---|
Calculated MW | ~47.0 kDa. Mouse PEDF (aa 20-417) is fused at the C-terminus to a FLAG®-tag. |
Gene ID | 20317 |
---|---|
Gene Symbol | Serpinf1 |
Other Names | Pigment Epithelium-derived Factor; Stromal Cell-derived Factor 3; Serpin F1; Caspin |
Gene Source | Mouse |
Source | CHO cells |
Assay&Purity | SDS-PAGE; ≥95% |
Assay2&Purity2 | N/A; |
Recombinant | Yes |
Target/Specificity | PEDF |
Application Notes | Reconstitute with 100 µl sterile distilled water. |
Format | Lyophilized |
Storage | -20°C; Lyophilized in PBS. |
Thousands of laboratories across the world have published research that depended on the performance of antibodies from Abcepta to advance their research. Check out links to articles that cite our products in major peer-reviewed journals, organized by research category.
info@abcepta.com, and receive a free "I Love Antibodies" mug.
Provided below are standard protocols that you may find useful for product applications.
Background
Pigment epithelium-derived factor (PEDF) is a 47 kDa secreted glycoprotein that belongs to the non-inhibitory serpin family group. PEDF is widely expressed in adult and fetal tissues, including brain, spinal cord, plasma, bone, prostate, pancreas, heart and lung. PEDF acts as an angiogenesis inhibitor with neurotrophic, immunomodulation and antitumor properties. It functions as anti-angiogenic agent by counterbalancing the proangiogenic effect of VEGF. PEDF is one of the most abundant proteins released by adipocytes and induces insulin resistance in adipocytes and human skeletal muscle cells. Recently, it has been reported that PEDF is sufficient to maintain the self-renewal of pluripotent human embryonic stem cells.
References
Shirozu M.,et al.Genomics 37:273-280(1996).
Kozaki K.,et al.J. Biol. Chem. 273:15125-15130(1998).
Singh V.K.,et al.Mol. Vis. 4:7-7(1998).
Tombran-Tink J.,et al.Submitted (OCT-1998) to the EMBL/GenBank/DDBJ databases.
Abramson L.P.,et al.J. Pediatr. Surg. 38:336-342(2003).
If you have used an Abcepta product and would like to share how it has performed, please click on the "Submit Review" button and provide the requested information. Our staff will examine and post your review and contact you if needed.
If you have any additional inquiries please email technical services at tech@abcepta.com.